Bethany Sensenig
Chief Financial Officer @Radius Health, Inc
Signup · Get unlimited contacts
WORK HISTORY
Chief Financial Officer @Radius Health, Inc
Radius Health, Inc. is a global biopharmaceutical company focused on addressing unmet medical needs in the areas of bone health and other related areas. Radius’ lead product, TYMLOS® (abaloparatide) injection, was approved by the U.S. Food and Drug Administration in April 2017 for the treatment of postmenopausal women with osteoporosis at high risk for fracture, and in December 2022 to increase bone density in men with osteoporosis at high risk for fracture. Radius also recently announced an exclusive licensing and distribution agreement for the U.S. rights to BINOSTO® (alendronate sodium) effervescent tablet for oral solution, expanding the Company’s presence in bone health.
EDUCATION
Western Carolina University
Masters, Business Administration
Montreat College
Bachelors of Science, Accounting & Business Management
ABOUT BETHANY SENSENIG
As a global, strategic C-suite executive and SEC Qualified Financial Expert, I have 25+…
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.